Clinical Trial Update: Saccharomyces Boulardii in Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Saccharomyces boulardii for diarrhea-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Aga Khan University | Conditions: Diarrhea Dominant Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED